Host gut-immune interface

The host gut-immune interface is a complex physiological boundary comprising the intestinal epithelium, the commensal microbiota, and the underlying mucosal immune system. Its primary biological function is to maintain homeostasis by facilitating nutrient absorption while simultaneously providing a robust defense against pathogens and maintaining oral tolerance to harmless antigens (Mowat & Agace, 2014, Nature Reviews Immunology). This interface includes physical barriers like the mucus layer and tight junctions, as well as specialized immune cells within the gut-associated lymphoid tissue (GALT) (Okumura & Takeda, 2017, Nature Reviews Immunology). The interaction between these components ensures that the immune system does not overreact to the trillions of microbes residing in the lumen. Dysregulation of this interface is a central driver of inflammatory bowel diseases (IBD), such as Crohn's disease and ulcerative colitis, where a breakdown in barrier function leads to inappropriate immune activation (Neurath, 2017, Nature Reviews Gastroenterology & Hepatology). Furthermore, chronic inflammation at this site has been linked to systemic conditions, including metabolic syndrome and certain autoimmune disorders. Therapeutic interventions targeting this interface aim to restore balance by inhibiting pro-inflammatory cytokines or preventing the recruitment of inflammatory cells to the gut wall (Walsham & Sherwood, 2016, Clinical and Experimental Gastroenterology). Modern drug development also explores the modulation of the microbiota and the reinforcement of the epithelial barrier to treat these conditions.

Other names

Gut-associated lymphoid tissueGALTIntestinal mucosal immune systemGut-immune axisIntestinal barrierMucosal immune system

Drugs targeting this interface function by neutralizing pro-inflammatory cytokines, blocking the adhesion and migration of lymphocytes into the gut mucosa, or inhibiting intracellular signaling pathways that drive chronic inflammation.